[1]
S. Samin and M. H. Utsha, “Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer”, Bangla J Med Phys, vol. 16, no. 1, pp. 56–64, Dec. 2025.